申请人:SAPOUNTZIS Ioannis
公开号:US20110071158A1
公开(公告)日:2011-03-24
The present invention encompasses compounds of general formula (1)
wherein B, R
1
to R
5
, R
x
, m and n are defined as in claim
1
, which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, and their use in such treatment.
本发明涵盖了一般式(1)的化合物,其中B、R1至R5、Rx、m和n如权利要求1所定义,适用于治疗由过度或异常细胞增殖所特征的疾病,并且它们在这种治疗中的使用。